Chemotherapy Devices Market, By Product (Catheter, Cannula, Pump, Others), By End User (Hospitals, Clinics, Homecare Settings), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Oct 2023

Code : CMI2231

Pages :178

Formats :

Excel and PDF

Industry : Medical Devices

Market News

Global Chemotherapy Devices Market : Key Developments

In June 2023, Merit Medical Systems, Inc., a medical device company, announced that it had acquired dialysis catheter product portfolio and the BioSentry Tract Sealant System from AngioDynamics, a global provider of industry-leading medical devices that are used for the treatment of cancer and peripheral vascular disease.
In June 2023, Merit Medical Systems, Inc., a leading manufacturer of proprietary medical devices that are used in interventional, diagnostic, and therapeutic procedures, announced that it had acquired surfacer inside-out access catheter system from Bluegrass Vascular Technologies, Inc., a U.S.-based medical technology company, in a total cash consideration of US$ 32.5 Mn. .
On June 22, 2022, Delta Med, a medical supply company, and Adria Med, an elastomeric pump developing company, announced a strategic partnership to expand its product portfolio and strengthen its market position in the infusion pump system.
In March 2022, Shanghai MicroPort Lifesciences Co., Ltd., a biotechnology company, announced that it had received marketing approval from China’s National Medical Products Administration (NMPA) for its independently-developed new AutoEx Chemotherapy Infusion Pump (AutoEx).
In January 2022, ICU Medical, Inc., a global medical device company, announced the completion of the acquisition of Smiths Medical from Smiths Group plc, a multinational engineering firm. Smiths Medical manufactures syringe and ambulatory infusion devices, and provides vascular access devices and critical care products.